Bromazine
 | |
| Clinical data | |
|---|---|
| Trade names | Ambodryl, Ambrodil, Deserol |
| Other names | Bromodiphenhydramine; Bromdiphenhydramine |
| MedlinePlus | a682065 |
| Routes of administration | Oral |
| ATC code | |
| Pharmacokinetic data | |
| Bioavailability | High |
| Protein binding | 96% |
| Metabolism | Mostly hepatic (CYP-mediated), also renal |
| Elimination half-life | 1 to 4 hours |
| Identifiers | |
| |
JSmol) | |
| |
| |
  (what is this?) (verify) | |
Bromazine, sold under the brand names Ambodryl, Ambrodil, and Deserol among others, also known as bromodiphenhydramine, is an
Synthesis
Grignard reaction between
deanol
completed the synthesis of Bromazine (4).
Side effects
Continuous and/or cumulative use of
References
- ^ OCLC 1058412474.
- ^ ISBN 978-3-88763-075-1.
- ^ Baker CE (1974). Physicians' Desk Reference (28th ed.). Oradell, NJ 07649: Medical Economics Company. pp. 1076, 1081.
{{cite book}}: CS1 maint: location (link) - PMID 23173575.
- PMID 14377226.
- S2CID 253644478.
- ^ US 2527963, Rieveschl Jr G, "Beta-dimethylamino-ethyl rho-halobenzhydryl ethers and their salts", issued 31 October 1950, assigned to Parke Davis & Co.
- PMID 25621434.
- PMID 19636034.